pubmed-article:20606424 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C2752009 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C0205160 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C0205125 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C0520997 | lld:lifeskim |
pubmed-article:20606424 | lifeskim:mentions | umls-concept:C0150312 | lld:lifeskim |
pubmed-article:20606424 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:20606424 | pubmed:dateCreated | 2010-8-9 | lld:pubmed |
pubmed-article:20606424 | pubmed:abstractText | The impact of deep white matter lesions observed at the corona radiata on diffusion-weighted MRI (DWI-W lesions) on the clinical recovery of patients after tissue plasminogen activator (tPA) therapy is unclear. Our goal was to elucidate whether DWI findings before tPA could predict clinical recovery. | lld:pubmed |
pubmed-article:20606424 | pubmed:language | eng | lld:pubmed |
pubmed-article:20606424 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20606424 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20606424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20606424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20606424 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20606424 | pubmed:month | Aug | lld:pubmed |
pubmed-article:20606424 | pubmed:issn | 1421-9786 | lld:pubmed |
pubmed-article:20606424 | pubmed:author | pubmed-author:HiranoTeruyuk... | lld:pubmed |
pubmed-article:20606424 | pubmed:author | pubmed-author:UchinoMakotoM | lld:pubmed |
pubmed-article:20606424 | pubmed:author | pubmed-author:InatomiYuichi... | lld:pubmed |
pubmed-article:20606424 | pubmed:author | pubmed-author:YoneharaToshi... | lld:pubmed |
pubmed-article:20606424 | pubmed:author | pubmed-author:KawanoHiroyuk... | lld:pubmed |
pubmed-article:20606424 | pubmed:author | pubmed-author:TerasakiTadas... | lld:pubmed |
pubmed-article:20606424 | pubmed:copyrightInfo | Copyright 2010 S. Karger AG, Basel. | lld:pubmed |
pubmed-article:20606424 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20606424 | pubmed:volume | 30 | lld:pubmed |
pubmed-article:20606424 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20606424 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20606424 | pubmed:pagination | 230-6 | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:meshHeading | pubmed-meshheading:20606424... | lld:pubmed |
pubmed-article:20606424 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20606424 | pubmed:articleTitle | Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis. | lld:pubmed |
pubmed-article:20606424 | pubmed:affiliation | Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. | lld:pubmed |
pubmed-article:20606424 | pubmed:publicationType | Journal Article | lld:pubmed |